[Side effects of combined antineoplastic chemotherapy on hemostasis in patients with breast cancer].
作者信息
Pinto Pedrazzi A H, de Souza A M
出版信息
Rev Fac Farm Odontol Ribeiro Preto. 1982 Jan-Jun;19(1):29-41.
PMID:6964932
Abstract
摘要
相似文献
1
[Side effects of combined antineoplastic chemotherapy on hemostasis in patients with breast cancer].[联合抗肿瘤化疗对乳腺癌患者止血功能的副作用]
Rev Fac Farm Odontol Ribeiro Preto. 1982 Jan-Jun;19(1):29-41.
2
[Sequential combination chemotherapy in metastatic cancer of the breast].[转移性乳腺癌的序贯联合化疗]
Medicina (B Aires). 1984;44(1):15-22.
4
5
Potential risk of a common hereditary thrombophilia and adjuvant chemotherapy for low-stage breast cancer.
J Clin Oncol. 2005 Jun 20;23(18):4242-3. doi: 10.1200/JCO.2004.00.4226.
6
[Use of dexamethasone as an antiemetic in patients with breast cancer treated with the CMF regimen].
Przegl Lek. 1994;51(5):203-5.
7
Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.贫血是接受辅助性环磷酰胺/甲氨蝶呤/5-氟尿嘧啶化疗的绝经前原发性乳腺癌患者局部无复发生存的一个重要预后因素。
Clin Cancer Res. 2008 Apr 1;14(7):2082-7. doi: 10.1158/1078-0432.CCR-07-2068.
8
A comparison of patient-reported side effects among three chemotherapy regimens for breast cancer.三种乳腺癌化疗方案患者报告的副作用比较。
Cancer Pract. 1994 Jan-Feb;2(1):57-62.
9
Recall of UVB-induced erythema in breast cancer patient receiving multiple drug chemotherapy.接受多种药物化疗的乳腺癌患者中紫外线B诱导红斑的回忆反应
Photodermatol. 1984 Jun;1(3):129-32.
10
[Secondary effects of adjuvant therapy].[辅助治疗的次要效应]
Minerva Ginecol. 1985 Jun;37(6):319-28.
Zotero 插件